Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Affinity 1: Technosphere Insulin vs Insulin Aspart in Type 1 Diabetes
NCT01445951Phase 3Completed
- Sponsor
- MannKind
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of TI-Inhalation Powder B in type 1 diabetes mellitus (T1D), sponsored by MannKind. Started Sep 2011; status: completed.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01445951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445951.